Obesity Clinical Trial
— M-DExOfficial title:
Weight Management in Rural Communities
| Verified date | March 2024 |
| Source | University of Kansas |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The goal of this study is to evaluate the effect of three weight management interventions (group phone conference calls, individual phone calls, and enhanced usual care) on weight across 18 months in overweight and obese adults recruited through and treated by rural primary care clinics.
| Status | Completed |
| Enrollment | 187 |
| Est. completion date | October 2021 |
| Est. primary completion date | April 2020 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 21 Years and older |
| Eligibility | Inclusion Criteria: - Body mass index 25 to 45 kg/m2 - Clearance from primary care physician Exclusion Criteria: - Unable to participate in moderate intensity physical activity - Participation in weight loss or physical activity program in previous 6 months - Greater than 3, 30-min bouts of planned exercise/week - Not weight stable (+/-4.6 kg) for 3 months prior to intake - Unwilling to be randomized to 1 of the 3 study groups - Report being pregnant during the previous 6 months or planned pregnancy in the following 18 months - Serious medical risk such as cancer, recent cardiac event - Current use of antipsychotics or untreated depression - Adherence to specialized diet regimens (food allergy, vegetarian, macrobiotic) - Binge eating disorder - Planning to movie to a location and no longer having access to rural clinic site |
| Country | Name | City | State |
|---|---|---|---|
| United States | Energy Balance Lab, The University of Kansas | Lawrence | Kansas |
| Lead Sponsor | Collaborator |
|---|---|
| University of Kansas | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Mean Weight Change Over 6 Months | Mean weight change (kg) of participants between the three study groups. | Change in baseline to 6 months | |
| Secondary | Change in BMI Across 6 Months | Mean BMI change (kg/m^2) of participants between the three study groups. | Change from baseline to 6 months | |
| Secondary | Change in Waist Circumference Across 6 Months | Mean waist circumference change (cm) in the three study groups. | Change from baseline - 6 months | |
| Secondary | Triglycerides | Mean change in fasting triglycerides will be compared across all treatment arms. | Change from baseline to 6 months | |
| Secondary | HDL-cholesterol | Mean change in fasting HDL-cholesterol will be compared across all treatment arms. | Change from baseline to 6 months | |
| Secondary | Change in Systolic Blood Pressure Across 6 Months | Mean change in systolic blood pressure will be compared across all treatment arms. | Change from baseline to 6 months | |
| Secondary | Change in Fasting Glucose Across 6 Months | Mean change in fasting glucose will be compared across all treatment arms. | Change from baseline to 6 months | |
| Secondary | Cost Effectiveness at 6 Months | Cost effectiveness was calculated for the group as the average total cost of the intervention arm (GP or IP) divided by the average weight loss at 6 months of the intervention arm. Costs associated with delivering the 6-month weight loss intervention, including supplies and intervention implementation, were estimated in 2019 U.S. dollars. Supply costs, i.e., pedometers, participant notebooks, providing and shipping low-calorie shakes and printed materials for the GP and IP arms. Implementation costs, i.e., time devoted to interventionist training, preparation and delivery of behavioral sessions and email contacts with participants were estimated as the time spent in these activities obtained from interventionist time sheets multiplied by interventionists hourly wage. Due to the cost effectiveness outcome measure being a ratio between two random variables, there are no dispersion/precision measures reported. | 6 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |